Publication | Open Access
Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
168
Citations
41
References
2020
Year
A robust immune-related prognostic signature with great performances in multiple LUAD cohorts was developed in this study.
| Year | Citations | |
|---|---|---|
Page 1
Page 1